2019 Pharma Quality Outlook

Performance Becomes a Priority

Download Whitepaper

* Your information is safe with us. We hate SPAM too.

Compliance is still king, but its lead is shrinking.

While compliance remains the top quality goal for pharmaceutical industry quality teams in 2019, economic performance could soon take the top spot.

According to the 2019 Pharma Quality Outlook Report—a survey sponsored by Sparta Systems and conducted by Pharmaceutical Technology—66 percent of industry executives named compliance as a top goal, down ten percent from last year. Meanwhile, over a third (39 percent) say that economic performance is now their top objective, a four percent increase.

Read the full report to learn how quality teams plan to impact company-wide performance and what obstacles are keeping them from achieving their goals.

Download the survey report to learn:

  • Why performance may soon replace compliance as the top quality goal

  • How quality departments plan to impact economic performance

  • What challenges are preventing teams from accomplishing their quality goals

  • How quality teams can overcome obstacles and drive company-wide performance

Sparta Systems, a Honeywell Company, brings leading-edge quality management solutions to regulated industries. With nearly three decades of experience, Sparta provides enterprise and cloud-based QMS software solutions that help companies go to market faster while minimizing product risks and ensuring compliance. Sparta is an innovator in its field and is driving smart quality with first-of-its-kind AI-enabled quality solutions. By applying the latest digital technologies, our products simplify the process of quality management and guide customers toward proactive quality. ​

The combination of Sparta Systems and Honeywell brings together Sparta’s quality management leadership with over 100 years of industrial and software expertise from Honeywell. Together, Sparta and Honeywell will shape the future of digital quality and operational excellence for the life sciences industry.